Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Projected Growth Rate of the Cell And Gene Therapy Supply Chain/Logistics Market from 2024 to 2033?
In recent times, there has been a quick expansion in the market size of the cell and gene therapy supply chain/logistics industry. The sector will see a hike from $1.25 billion in 2023 to $1.4 billion in 2024, signaling a compound annual growth rate (CAGR) of 12.6%. This notable upward trajectory during the historic period is a result of increased chronic disease prevalence, efficient utilization of supply chain necessities, a rise in drug integrity maintenance, improved regulatory structures, and a heightened focus on risk reduction and adherence to guidelines.
The market size of the supply chain/logistics for cell and gene therapy is projected to experience a rapid surge in the coming years. It’s anticipated to reach a value of $2.15 billion in 2028, growing at a compound annual growth rate (CAGR) of 11.2%. This growth during the forecast period is likely due to the increase in personalized medicine, the rise of cell-free therapies, the prevalence of chronic illnesses, the expansion of the global cell therapy manufacturing market, and the effective implementation of supply chain requirements. The forecast period will also see trends such as heightened spending on research and development, the adoption of cutting-edge technologies, favorable initiatives and programs for increased accessibility, as well as collaborations and partnerships among cell and gene therapy firms, supply chain providers, and logistics companies, offering bespoke services to assist with any patient identification stage.
Claim Your Free Sample of the Global Cell And Gene Therapy Supply Chain/Logistics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp
What Are the Key Drivers of Growth in the cell and gene therapy supply chain/logistics Market?
The surging demand for cell and gene treatments is propelling the cell and gene therapy supply chain/logistics sector. These therapies, which offer potential breakthroughs for diseases previously deemed incurable, involve altering cells or genes. Proper temperature and storage conditions are essential for these therapies, requiring efficient supply chain and logistics services to ensure appropriate sourcing, distribution, and storage. As per findings from the US research portal, Cell & Gene, in February 2022, private investment in this field reached $68 billion in 2021. Additionally, 2021 saw a 10% rise in the number of approved cell and gene therapies. Hence, the escalating requirement for these therapies is significantly contributing to the expansion of the cell and gene therapy supply chain/logistics market.
What Are the Notable Segments in the Cell And Gene Therapy Supply Chain/Logistics Market?
1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
Which Emerging Trends Are Altering the Cell And Gene Therapy Supply Chain/Logistics Market?
Current technological advancement forms a significant trend that is being adopted in the market for the cell and gene therapy supply chain/logistics. Numerous leading firms within this industry have been creating modern technological platforms specifically for cell and gene therapies in order to maintain their market standing. For instance, AmerisourceBergen Corporation., a healthcare company based in the US with a focus on cell and gene therapy supply chain logistics, in April 2023, started off with the Cell and Gene Therapy (CGT) Integration Hub. The said hub is managed by AmerisourceBergen’s cutting-edge customer relationship management (CRM) system and it can be incorporated into the biopharma platform, thereby improving the monitoring process for the formulation and distribution of cell and gene therapies.
Order Now for Fast Delivery of Your Cell And Gene Therapy Supply Chain/Logistics Market Report!
Which Regions Are Most Influential in Expanding the Cell And Gene Therapy Supply Chain/Logistics Market?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2023. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cell and gene therapy supply chain/logistics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Cell And Gene Therapy Supply Chain/Logistics Market Include
1. Cell And Gene Therapy Supply Chain/Logistics Market Executive Summary
2. Cell And Gene Therapy Supply Chain/Logistics Market Segments
3. Cell And Gene Therapy Supply Chain/Logistics Market Size And Template Market Growth Rate
4. Key Cell And Gene Therapy Supply Chain/Logistics Market Trends
5. Major Cell And Gene Therapy Supply Chain/Logistics Market Drivers
……
25. Key Mergers And Acquisitions In The Cell And Gene Therapy Supply Chain/Logistics Market
26. Top Cell And Gene Therapy Supply Chain/Logistics Companies
27. Cell And Gene Therapy Supply Chain/Logistics Market Opportunities And Strategies
28. Cell And Gene Therapy Supply Chain/Logistics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Stem Cell Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Cell Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report
Cell and Gene Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
